Loading company…
Mikrobiomik develops biopharmaceutical products based on the human microbiome.
Mikrobiomik Healthcare Company S.L. develops drugs from the human microbiome, including MBK-001, a capsule for recurrent CDI, and fecal microbiota transplantation services. Founded in 2018 and based in Bizkaia, Spain, the company received undisclosed venture funding from Seed Capital de Bizkaia in December 2021 and EUR 1.1 million in venture funding in September 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Mikrobiomik Healthcare Company S.L.? This is my company